ArticleInternational journal for equity in health2025
Unveiling the gendered abyss: exploring the case of women with lymphatic filariasis and the path to inclusive care in India.
Article in International journal for equity in health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Intersectional dimensions of stigma in neglected tropical diseases: a systematic review of evidence and implications for equity-based health policy.BMC public health · 2026Pooled it
- Global, regional, and national disease burden of arthropod-borne diseases: Projections to 2030 based on the global burden of disease study 2021.PLoS neglected tropical diseases · 2026Article
- Living with Filariasis: Unseen Struggles of a Neglected Disease.The Yale journal of biology and medicine · 2025Review
- Global insights can accelerate India's journey towards the elimination of lymphatic filariasis as a public health problem.BMJ global health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionLymphatic filariasis (LF), a neglected tropical disease (NTD), affects tropical regions marked by poor socioeconomic conditions and often results in non-curable filarial lymphedema. The impact of LF is often disproportionate, adversely affecting women due to a multitude of intersecting disadvantages. There has been little effort to understand the unique illness experience of women with LF.
methodsTo explore the interplay between gender and the illness experience of women afflicted with filarial lymphoedema, this qualitative study mapped the experience of 18 women and the perceptions of 18 men with lymphatic filariasis. Data collection involved 12 in-depth interviews and four focus group discussions, with equal gender separation. The content generated was analyzed using a hybrid thematic analysis approach.
resultsThe study shows that individuals with filarial lymphedema, regardless of gender, encounter numerous challenges. However, certain aspects, like cultural gender norms paired with socioeconomic disadvantages, exert a disproportionate burden on women, which adversely affects their physical health, health-seeking behavior, and mental health. While the study highlights the intersectional lived experiences of women with LF, its focus on women's experiences may limit broader generalizability across genders.
conclusionsAddressing the factors that impact the lived experiences of women with lymphatic filariasis is an essential but complex task that requires positive changes across various domains. Targeted mental health interventions and robust family support systems can play a pivotal role in improving the health outcomes of affected individuals. Also, gender-informed intersectional research on the illness experiences of women with LF can give valuable insights to tailor better morbidity management policies and practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.